These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36230066)

  • 1. Antibacterial Regularity Mining Beneath the Systematic Activity Database of Lipopeptides Brevilaterins: An Instructive Activity Handbook for Its Food Application.
    Liu Y; Han P; Jia Y; Chen Z; Li S; Ma A
    Foods; 2022 Sep; 11(19):. PubMed ID: 36230066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial mechanism of brevilaterin B: an amphiphilic lipopeptide targeting the membrane of Listeria monocytogenes.
    Liu Y; Ma A; Han P; Chen Z; Jia Y
    Appl Microbiol Biotechnol; 2020 Dec; 104(24):10531-10539. PubMed ID: 33170327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An accurate strategy for pointing the key biocatalytic sites of bre2691A protein for modification of the brevilaterin from Brevibacillus laterosporus.
    Han P; Chen Z; Liu Y; Ma A; Li S; Jia Y
    Microb Cell Fact; 2022 Sep; 21(1):196. PubMed ID: 36123650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brevilaterin B from Brevibacillus laterosporus has selective antitumor activity and induces apoptosis in epidermal cancer.
    Chen Z; Wang L; Liu Y; Han P; Hong D; Li S; Ma A; Jia Y
    World J Microbiol Biotechnol; 2022 Aug; 38(11):201. PubMed ID: 35999383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum antifungal activity of lipopeptide brevilaterin B and its inhibition effects against Fusarium oxysporum and Penicillium chrysogenum.
    Liu Y; Chen Z; Liu L; Han P; Wang X; Li S; Ma A; Jia Y
    J Appl Microbiol; 2022 Feb; 132(2):1330-1342. PubMed ID: 34480826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Property Cytotoxicity and Mechanism of Food Preservative Brevilaterins against Human Gastric Cancer Cells.
    Chen Z; Hong D; Li S; Jia Y
    Foods; 2023 Apr; 12(8):. PubMed ID: 37107527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination Therapy for Bacterial Pathogens: Naturally Derived Antimicrobial Drugs Combined with
    Bamunuarachchi NI; Khan F; Kim YM
    Infect Disord Drug Targets; 2022; 22(1):e230821195790. PubMed ID: 34425745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Organization of Brevilaterin Biosynthesis in
    Han P; Chen Z; Liu Y; Ma A; Li S; Jia Y
    J Agric Food Chem; 2022 Jun; 70(24):7471-7478. PubMed ID: 35675382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad-spectrum cytotoxicity to cancer cells of Brevilaterin C from Brevibacillus laterosporus and its specific mechanism on human epidermal cancer cells.
    Chen Z; Wang L; Hong D; Liu Y; Han P; Li S; Jia Y
    J Cell Biochem; 2022 Jul; 123(7):1237-1246. PubMed ID: 35656936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial activity of silver nanoparticles against multiple drug resistant strains].
    Chen X; Jiang J; Ren Z; Li J; Zhang H; Xu J; Du H
    Wei Sheng Wu Xue Bao; 2017 Apr; 57(4):539-49. PubMed ID: 29756737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial effect of copper sulfate against multi-drug resistant nosocomial pathogens isolated from clinical samples.
    Benhalima L; Amri S; Bensouilah M; Ouzrout R
    Pak J Med Sci; 2019; 35(5):1322-1328. PubMed ID: 31489000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Activity of
    Primavilla S; Pagano C; Roila R; Branciari R; Ranucci D; Valiani A; Ricci M; Perioli L
    Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36676009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.
    Seukep JA; Sandjo LP; Ngadjui BT; Kuete V
    BMC Complement Altern Med; 2016 Jul; 16():193. PubMed ID: 27386848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyathea gigantea (Cyatheaceae) as an antimicrobial agent against multidrug resistant organisms.
    Nath K; Talukdar AD; Bhattacharya MK; Bhowmik D; Chetri S; Choudhury D; Mitra A; Choudhury NA
    BMC Complement Altern Med; 2019 Oct; 19(1):279. PubMed ID: 31640666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioprospecting of a novel endophytic Bacillus velezensis FZ06 from leaves of Camellia assamica: Production of three groups of lipopeptides and the inhibition against food spoilage microorganisms.
    Li FZ; Zeng YJ; Zong MH; Yang JG; Lou WY
    J Biotechnol; 2020 Nov; 323():42-53. PubMed ID: 32739396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates.
    Mogana R; Adhikari A; Tzar MN; Ramliza R; Wiart C
    BMC Complement Med Ther; 2020 Feb; 20(1):55. PubMed ID: 32059725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
    Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
    J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
    Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
    Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined antibacterial effect of essential oils from three most commonly used Ethiopian traditional medicinal plants on multidrug resistant bacteria.
    Gadisa E; Weldearegay G; Desta K; Tsegaye G; Hailu S; Jote K; Takele A
    BMC Complement Altern Med; 2019 Jan; 19(1):24. PubMed ID: 30658640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of selected medicinal plants traditionally used in Vietnam against human pathogenic bacteria.
    Vu TT; Kim H; Tran VK; Le Dang Q; Nguyen HT; Kim H; Kim IS; Choi GJ; Kim JC
    BMC Complement Altern Med; 2016 Jan; 16():32. PubMed ID: 26819218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.